Celldex Therapeutics, Inc. (CLDX) Capital expenditures 2016–2025
Celldex Therapeutics, Inc. (CLDX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$2.7MFY2025 · since FY2016: $2.8M → $2.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.7M | +41.4% |
| FY2024 | $1.9M | +5.6% |
| FY2023 | $1.8M | -0.5% |
| FY2022 | $1.8M | +46.4% |
| FY2021 | $1.2M | -19.5% |
| FY2020 | $1.6M | +112.3% |
| FY2019 | $731,000 | -10.1% |
| FY2018 | $813,000 | -54.5% |
| FY2017 | $1.8M | -35.0% |
| FY2016 | $2.8M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice